Mayo Clinic First in US to Test Stem Cells in Pediatric Congenital Heart Disease Patients

ROCHESTER, Minn. — Mayo Clinic has announced the first U.S. stem cell clinical trial for pediatric congenital heart disease. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome (HLHS), a rare defect in which the left side of the heart is critically underdeveloped.